Literature DB >> 20530408

Overexpression of p150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancer.

J Haybaeck1, T O'Connor, R Spilka, G Spizzo, Ch Ensinger, G Mikuz, T Brunhuber, A Vogetseder, I Theurl, W Salvenmoser, H Draxl, R Bänziger, F Bachmann, G Schäfer, M Burger, P Obrist.   

Abstract

BACKGROUND: P150, a 150 kDa protein, was isolated from virally and oncogene-transformed mouse cell lines, partially purified and cloned. P150 is part of the large subunit of the eukaryotic translation initiation factor 3 with sequence homology to centrosomin A. A significant correlation between p150 expression and malignancy in breast, cervical and esophageal cancer have recently been demonstrated.
MATERIALS AND METHODS: Here, 110 colorectal carcinomas of different grades and stages, including lymph node and liver metastases were compared to adjacent normal mucosa by immunohistochemistry of P150. Western blot analysis of selected cases confirmed the expression levels determined by immunohistochemistry. Additionally, immuno-electron and laser scanning microscopy (LSM) was performed.
RESULTS: All investigated carcinomas revealed high levels of p150 protein compared to normal adjacent mucosa. The staining intensity was slightly heterogeneous, and positivity was correlated to the tumor grade with statistically significant differences of p150 expression between normal and neoplastic mucosa (p<0.0001, Kruskal-Wallis test). Western blots confirmed higher expression levels of p150 in the tumor. Immunogold labelling and LSM investigation showed high expression levels of p150 on the rough endoplasmic reticulum and polyribosomes, indicating that p150 is translationally active in these tumors.
CONCLUSION: Thus, we propose that p150 plays an important role in development and growth of colorectal carcinomas. Furthermore, p150 expression might provide us with reliable information on the biological behaviour of tumors and the clinical course of the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530408

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  26 in total

1.  Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.

Authors:  Zhifeng Lin; Liwen Xiong; Qiang Lin
Journal:  Med Oncol       Date:  2015-05-26       Impact factor: 3.064

2.  Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients.

Authors:  Xiaojing Xu; Lifang Han; Li Duan; Yingchun Zhao; Huaping Yang; Boting Zhou; Rui Ma; Ruixia Yuan; Honghao Zhou; Zhaoqian Liu
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

3.  Knockdown of elF3a inhibits collagen synthesis in renal fibroblasts via Inhibition of transforming growth factor-β1/Smad signaling pathway.

Authors:  Yun-Fang Zhang; Qi Wang; Jie Luo; Shen Yang; Jie-Lin Wang; Hong-Yan Li
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 4.  The biological and therapeutic relevance of mRNA translation in cancer.

Authors:  Sarah P Blagden; Anne E Willis
Journal:  Nat Rev Clin Oncol       Date:  2011-03-01       Impact factor: 66.675

Review 5.  eIF3: a factor for human health and disease.

Authors:  Andreia Gomes-Duarte; Rafaela Lacerda; Juliane Menezes; Luísa Romão
Journal:  RNA Biol       Date:  2017-11-13       Impact factor: 4.652

6.  eIF3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.

Authors:  Ji-Ye Yin; Zizheng Dong; Jian-Ting Zhang
Journal:  Methods Mol Biol       Date:  2017

7.  eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation.

Authors:  Rita Spilka; Christina Ernst; Helmut Bergler; Johannes Rainer; Susanne Flechsig; Alexander Vogetseder; Eva Lederer; Martin Benesch; Andrea Brunner; Stephan Geley; Andreas Eger; Felix Bachmann; Wolfgang Doppler; Peter Obrist; Johannes Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2014-07-29       Impact factor: 6.730

8.  Eukaryotic translation initiation factor 3, subunit a, regulates the extracellular signal-regulated kinase pathway.

Authors:  Tian-Rui Xu; Rui-Fang Lu; David Romano; Andrew Pitt; Miles D Houslay; Graeme Milligan; Walter Kolch
Journal:  Mol Cell Biol       Date:  2011-10-24       Impact factor: 4.272

9.  Knockdown of eIF3a attenuated cell growth in K1 human thyroid cancer cells.

Authors:  Xucai Zheng; Shengying Wang; Shikai Hong; Jianjun Liu; Chenghao Jiang
Journal:  Genes Genomics       Date:  2021-02-17       Impact factor: 1.839

Review 10.  Role of RONS and eIFs in Cancer Progression.

Authors:  Yasmeen Ahmed Salaheldin; Salma Sayed Mohamed Mahmoud; Ebenezeri Erasto Ngowi; Vivian Aku Gbordzor; Tao Li; Dong-Dong Wu; Xin-Ying Ji
Journal:  Oxid Med Cell Longev       Date:  2021-07-05       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.